Literature DB >> 30483863

Interaction of host and Staphylococcus aureus protease-system regulates virulence and pathogenicity.

Vigyasa Singh1, Ujjal Jyoti Phukan2.   

Abstract

Staphylococcus aureus causes various health care- and community-associated infections as well as certain chronic TH2 driven inflammatory diseases. It is a potent pathogen with serious virulence and associated high morbidity. Severe pathogenicity is accredited to the S. aureus secreted virulence factors such as proteases and host protease modulators. These virulence factors promote adhesion and invasion of bacteria through damage of tight junction barrier and keratinocytes. They inhibit activation and transmigration of various immune cells such as neutrophils (and neutrophil proteases) to evade opsono-phagocytosis and intracellular bacterial killing. Additionally, they protect the bacteria from extracellular killing by disrupting integrity of extracellular matrix. Platelet activation and agglutination is also impaired by these factors. They also block the classical as well as alternative pathways of complement activation and assist in spread of infection through blood and tissue. As these factors are exquisite factors of S. aureus mediated disease development, we have focused on review of diversification of various protease-system associated virulence factors, their structural building, diverse role in disease development and available therapeutic counter measures. This review summarises the role of protease-associated virulence factors during invasion and progression of disease.

Entities:  

Keywords:  Modulators of proteases; Proteases; Regulators of immune cells; Staphylococcus aureus; Virulence factors

Mesh:

Substances:

Year:  2018        PMID: 30483863     DOI: 10.1007/s00430-018-0573-y

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  249 in total

Review 1.  Staphylococcal manipulation of host immune responses.

Authors:  Vilasack Thammavongsa; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Nat Rev Microbiol       Date:  2015-09       Impact factor: 60.633

2.  Argatroban inhibits staphylothrombin.

Authors:  A Hijikata-Okunomiya; N Kataoka
Journal:  J Thromb Haemost       Date:  2003-09       Impact factor: 5.824

3.  Extracellular proteins of Staphylococcus aureus and the role of SarA and sigma B.

Authors:  A K Ziebandt; H Weber; J Rudolph; R Schmid; D Höper; S Engelmann; M Hecker
Journal:  Proteomics       Date:  2001-04       Impact factor: 3.984

4.  Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation.

Authors:  Katherine J Lauderdale; Blaise R Boles; Ambrose L Cheung; Alexander R Horswill
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

5.  Human immune proteome in experimental colonization with Staphylococcus aureus.

Authors:  Silva Holtfreter; Thi Thu Hoai Nguyen; Heiman Wertheim; Leif Steil; Harald Kusch; Quoc Phong Truong; Susanne Engelmann; Michael Hecker; Uwe Völker; Alex van Belkum; Barbara M Bröker
Journal:  Clin Vaccine Immunol       Date:  2009-09-16

6.  Degradation of elastin by a cysteine proteinase from Staphylococcus aureus.

Authors:  J Potempa; A Dubin; G Korzus; J Travis
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

7.  Serine protease EpiP from Staphylococcus epidermidis catalyzes the processing of the epidermin precursor peptide.

Authors:  S Geissler; F Götz; T Kupke
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

8.  The development of first Staphylococcus aureus SplB protease inhibitors: phosphonic analogues of glutamine.

Authors:  Burchacka Ewa; Walczak Maciej; Sieńczyk Marcin; Dubin Grzegorz; Zdżalik Michał; Potempa Jan; Oleksyszyn Józef
Journal:  Bioorg Med Chem Lett       Date:  2012-07-13       Impact factor: 2.823

9.  Impact of individual extracellular proteases on Staphylococcus aureus biofilm formation in diverse clinical isolates and their isogenic sarA mutants.

Authors:  Allister J Loughran; Danielle N Atwood; Allison C Anthony; Nada S Harik; Horace J Spencer; Karen E Beenken; Mark S Smeltzer
Journal:  Microbiologyopen       Date:  2014-09-25       Impact factor: 3.139

10.  Comparison of the transmembrane mucins MUC1 and MUC16 in epithelial barrier function.

Authors:  Ilene K Gipson; Sandra Spurr-Michaud; Ann Tisdale; Balaraj B Menon
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

View more
  7 in total

1.  Gamma irradiation effectuality on the antibacterial and bioactivity behavior of multicomponent borate glasses against methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  W M Abd-Allah; Rasha Mohammad Fathy
Journal:  J Biol Inorg Chem       Date:  2022-01-22       Impact factor: 3.358

2.  Otopathogenic Staphylococcus aureus Invades Human Middle Ear Epithelial Cells Primarily through Cholesterol Dependent Pathway.

Authors:  Rahul Mittal; Luca H Debs; Amit P Patel; Desiree Nguyen; Patricia Blackwelder; Denise Yan; Paulo H Weckwerth; Xue Zhong Liu
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

3.  On the Etiological Relevance of Escherichia coli and Staphylococcus aureus in Superficial and Deep Infections - A Hypothesis-Forming, Retrospective Assessment.

Authors:  Hagen Frickmann; Andreas Hahn; Stefan Berlec; Johannes Ulrich; Moritz Jansson; Norbert Georg Schwarz; Philipp Warnke; Andreas Podbielski
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2019-10-16

Review 4.  Smart Hydrogels for Advanced Drug Delivery Systems.

Authors:  Aydin Bordbar-Khiabani; Michael Gasik
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

5.  Thymus zygis Essential Oil: Phytochemical Characterization, Bioactivity Evaluation and Synergistic Effect with Antibiotics against Staphylococcus aureus.

Authors:  Alexandra Coimbra; Sónia Miguel; Maximiano Ribeiro; Paula Coutinho; Lúcia Silva; Ana Paula Duarte; Susana Ferreira
Journal:  Antibiotics (Basel)       Date:  2022-01-24

6.  A vancomycin resistance-associated WalK(S221P) mutation attenuates the virulence of vancomycin-intermediate Staphylococcus aureus.

Authors:  Yifan Rao; Huagang Peng; Weilong Shang; Zhen Hu; Yi Yang; Li Tan; Ming Li; Renjie Zhou; Xiancai Rao
Journal:  J Adv Res       Date:  2021-11-26       Impact factor: 12.822

Review 7.  Staphylococcus aureus-A Known Opponent against Host Defense Mechanisms and Vaccine Development-Do We Still Have a Chance to Win?

Authors:  Urszula Wójcik-Bojek; Barbara Różalska; Beata Sadowska
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.